MARC record from Internet Archive

LEADER: 03854cam 2200829 a 4500
001 ocm34912731
003 OCoLC
005 20191226225447.0
008 960523s1996 maua b 001 0 eng
010 $a 96025407
040 $aDNLM/DLC$beng$cDLC$dNLM$dC#P$dUKM$dMUQ$dBAKER$dNLGGC$dYDXCP$dBTCTA$dOCLCG$dNLE$dZWZ$dBDX$dOCLCO$dCHVBK$dOCLCQ$dEUW$dOCLCQ$dLFM$dOCLCA$dOCLCF$dOCLCO
015 $aGB9777288$2bnb
016 7 $a9607894$2DNLM
019 $a38113206
020 $a0674068092$q(alk. paper)
020 $a9780674068094$q(alk. paper)
035 $a(OCoLC)34912731$z(OCoLC)38113206
050 00 $aRC271.I47$bL68 1996
060 00 $a1997 C-291
060 10 $aQZ 266$bL922b 1996
082 00 $a616.994061$221
084 $a44.81$2bcl
100 1 $aLo wy, Ilana,$d1948-
245 10 $aBetween bench and bedside :$bscience, healing, and interleukin-2 in a cancer ward /$cIlana Lo wy.
246 30 $aScience, healing, and interleukin-2 in a cancer ward
260 $aCambridge, Mass. :$bHarvard University Press,$c1996.
300 $a370 pages :$billustrations ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references (pages 289-361) and index.
505 0 $aIntroduction: Observing a Clinical Experiment in Context -- 1. The Culture of Clinical Experimentation in Oncology -- 2. Cancer Immunotherapy, 1894-1979 -- 3. Cancer Immunotherapy and Mass Production of Biological Agents, 1980-1990 -- 4. The IL-2 Trial at the Cancer Foundation: A Personal View -- 5. Making the IL-2 Trial Work: Professional Cultures, Jurisdictions, and Practices -- 6. A Science-Laden Pathology between Bench and Bedside.
650 0 $aInterleukin-2$xTherapeutic use.
650 0 $aCancer$xImmunotherapy.
650 0 $aOncologists$xAttitudes.
650 0 $aClinical trials$xPhilosophy.
650 6 $aInterleukine 2$xEmploi en the rapeutique.
650 6 $aCancer$xImmunothe rapie.
650 6 $aCance rologues$xAttitudes.
650 6 $aE tudes cliniques$xPhilosophie.
650 6 $aCancer$xTraitement.
650 7 $aInterleukine-2$xusage the rapeutique.$2fmesh
650 7 $aTumeurs$xThe rapeutique.$2fmesh
650 7 $aEssais cliniques comme sujet.$2fmesh
650 17 $aInterleukine-2.$2gtt
650 17 $aImmunotherapie.$2gtt
650 7 $aKrebs$gMedizin$2gnd
650 7 $aTherapie$2gnd
650 7 $aCancer$xImmunotherapy.$2fast$0(OCoLC)fst00845386
650 7 $aInterleukin-2$xTherapeutic use.$2fast$0(OCoLC)fst00976423
650 7 $aOncologists$xAttitudes.$2fast$0(OCoLC)fst01045737
650 12 $aNeoplasms$xtherapy.$0https://id.nlm.nih.gov/mesh/D009369Q000628
650 22 $aClinical Trials as Topic.$0https://id.nlm.nih.gov/mesh/D002986
650 22 $aInterleukin-2$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D007376Q000627
655 7 $aMemoirs.$2rbgenr
655 2 $aPersonal Narrative.$0https://id.nlm.nih.gov/mesh/D062210
776 08 $iOnline version:$aLo wy, Ilana, 1948-$tBetween bench and bedside.$dCambridge, Mass. : Harvard University Press, 1996$w(OCoLC)606936752
776 08 $iOnline version:$aLo wy, Ilana, 1948-$tBetween bench and bedside.$dCambridge, Mass. : Harvard University Press, 1996$w(OCoLC)607810367
938 $aBaker & Taylor$bBKTY$c57.00$d57.00$i0674068092$n0002859832$sactive
938 $aBrodart$bBROD$n50538802$c$65.50
938 $aBaker and Taylor$bBTCP$n96025407
938 $aYBP Library Services$bYANK$n1281523
029 1 $aAU@$b000012350335
029 1 $aCHSLU$b000918444
029 1 $aCHVBK$b023600721
029 1 $aHEBIS$b052014355
029 1 $aNLGGC$b148988393
029 1 $aNLM$b9607894
029 1 $aYDXCP$b1281523
029 1 $aZWZ$b049090607
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 186 OTHER HOLDINGS